Aurinia Pharmaceuticals Inc., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], Debt SecuritiesIndenture • November 19th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [●], 20 , among Aurinia Pharmaceuticals Inc., an Alberta corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
AURINIA PHARMACEUTICALS INC. AND , AS WARRANT AGENT FORM OF COMMON SHARES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 19th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS COMMON SHARES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between AURINIA PHARMACEUTICALS INC., an Alberta corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
AURINIA PHARMACEUTICALS INC. (existing under the Business Corporations Act (Alberta)) Controlled Equity OfferingSMAurinia Pharmaceuticals Inc. • November 19th, 2021 • Pharmaceutical preparations • New York
Aurinia Pharmaceuticals Inc., a company existing under the Business Corporations Act (Alberta) (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
AURINIA PHARMACEUTICALS INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • November 19th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between AURINIA PHARMACEUTICALS INC., an Alberta corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
